Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 7.3% in the afternoon session after Evercore ISI Group upgraded the company's rating to "Outperform" from "In-Line" and raised its price ...

Azenta (AZTA) has come back into focus for investors after recent share price moves. The stock is up about 8.7% over the past 3 months but has shown weaker returns over the past year. See our latest ...

Throughout the last three months, 5 analysts have evaluated Azenta (NASDAQ:AZTA), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their ...

Life sciences company Azenta (NASDAQ:AZTA) reported Q3 CY2025 results , with sales up 5.5% year on year to $159.2 million. Its non-GAAP profit of $0.19 per share was in line with analysts’ consensus ...

Life sciences company Azenta (NASDAQ:AZTA) reported Q1 CY2025 results , with sales up 5.2% year on year to $143.4 million. Its non-GAAP profit of $0.07 per share was in line with analysts’ consensus ...

Azenta (NASDAQ:AZTA) is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

Azenta, Inc. is a Massachusetts headquartered company that is focused on the development and marketing of comprehensive biological and chemical compound sample management and genomic solutions. These ...

Azenta (NASDAQ:AZTA) will release its quarterly earnings report on Friday, 2025-11-21. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Azenta to report an earnings ...